semaglutide holland and barrett Microdose Holland & Barrett Fat Metaboliser

GLP-1 receptor agonist therapy, including semaglutide and tirzepatide, offers a physician-supervised path to meaningful, sustainable weight loss backed by clinical science.

Encourage people living with obesity to engage with weight management programmes

In an attempt to compensate for the loss, other pathways are upregulated, e.g., the increased use of ketones produced from fatty acids by astrocytes that are shuttled to neurons

Take control of your appetite with our innovative Appetite Suppression Patch

Semaglutide, a GLP-1 receptor agonist used primarily to regulate blood sugar and appetite, has been studied mostly in models of obesity and diabetes

Its made for individuals seeking a clean, plant-based daily capsule with transparent sourcing, mindful formulation, and no unnecessary additives.